WASHINGTON, DC—“Historically, it takes many years and lots of research money to go from the initial concept—an idea created in a lab—to the few of those trials that are successful and actually change clinical practice,” said Marc Blackman, MD.

WASHINGTON,DC—For the first time since federal research agencies began conducting research on Alzheimer’s disease (AD), there is a national plan designed to focus those efforts.

WASHINGTON, DC—Asking servicemembers and veteran patients about sleep can serve as a segue to conversations about other post-deployment issues that these patients might be experiencing, said Paula Domenici, PhD.

BETHESDA, MD—Even drugs that have been on the market for years, sometimes decades, are not immune from reexamination and relabeling brought about by new scientific discoveries. In the field of pharmacogenomics especially, new opportunities are presenting themselves to use new science to improve drug safety and dosing protocols.

WASHINGTON, DC—Diarrheal illnesses are among the most common nonbattle-related illnesses that troops experience when they go overseas, yet there is no vaccine against Enterotoxigenic Escherichia coli (ETEC), a common cause of bacterial diarrhea.

WASHINGTON, DC—Hospitalized children in the US are becoming infected with the bacteria Clostridium difficile (CDI) more frequently, according to researchers from the Uniformed Services University of the Health Sciences (USU) and Cincinnati Children’s Hospital Medical Center.

PENTAGON—A newly published study shows that psychiatric and behavioral health disorders were reduced by 78% in Army brigades that underwent a pre-deployment health screening program that focused on screening and then linking soldiers to care in theater, if needed.

A Randomized Controlled Trial on Women’s Substance Abuse Treatment (WPR)

Purpose: To examine the efficacy of an evidence-based gender-specific treatment model for women veterans with substance use disorder (SUD).

Strategic Timing of Antiretroviral Treatment

Objective: To find out if the chance of developing a serious illness or of getting AIDS is less if patients start taking HIV medicines at a time when their CD4-positive cell count is still fairly high.

WASHINGTON, DC—“A cure for Alzheimer’s (AD) has not been found on my watch, but the momentum is there,” said Marcelle Morrison-Bogorad, PhD, at what might be her last opportunity to speak before Congress as the director of the National Institute on Aging’s neuroscience division.